Navigating IPR and Biopiracy in Biotechnology

When researchers discover a drought-resistant gene in wild rice or develop a new fermentation process using traditional knowledge, who owns the innovation? This question sits at the heart of biotechnology’s most complex challenge: balancing intellectual property rights with ethical use of biological resources. As biotechnology advances rapidly, understanding how to protect innovations while preventing exploitation has become crucial for researchers, companies, and communities worldwide.

Understanding intellectual property rights in biotechnology 🔗

Intellectual property rights in biotechnology serve as protective mechanisms that safeguard innovations and encourage continued research and development. These protections are essential in a field where significant investments of time, resources, and expertise are required to develop new products and processes.

Patents provide inventors exclusive rights to their inventions for typically 20 years. In biotechnology, these may cover genetically modified organisms, specific gene sequences, or novel research methods. Beyond patents, other forms of IPR include trade secrets that protect confidential information like proprietary fermentation techniques, trademarks for product branding, and specialized plant variety protection for new cultivars developed through genetic engineering or conventional breeding.

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) establishes minimum standards for IPR protection across World Trade Organization member countries. TRIPS requires countries to provide patent protection for microorganisms and microbiological processes that are new, inventive, and capable of industrial application, while allowing exclusions for plants and animals. This framework has significant implications for biotechnology, as it mandates protection for many biotechnological inventions while attempting to balance commercial interests with public concerns.

The biopiracy problem 🔗

Biopiracy represents the unauthorized appropriation of knowledge and genetic resources from farming and indigenous communities by individuals or institutions seeking exclusive control through patents or intellectual property. Unlike ethical bioprospecting, which involves proper consent and benefit-sharing agreements, biopiracy occurs without permission or fair compensation to the source communities.

Real-world examples of biopiracy 🔗

Several high-profile cases illustrate how biopiracy affects communities. The neem tree case from India stands out as particularly significant. For centuries, Indian villagers used neem extracts as natural pesticides. However, when a U.S. company obtained patents for neem-based products in the 1990s, it raised serious concerns about the exploitation of traditional knowledge. After years of legal challenges, the European Patent Office eventually overturned the patent in 2000.

Similarly, turmeric, used medicinally in India for wound healing for centuries, was patented by the University of Mississippi in 1995 without crediting the traditional knowledge holders. These cases demonstrate how biopiracy can prevent indigenous communities from using their own biological resources and traditional knowledge that they developed and maintained over generations.

The impact on communities and biodiversity 🔗

Biopiracy harms indigenous populations in multiple ways. Without proper compensation for their traditional knowledge, communities may find that plants or resources they’ve used freely for generations suddenly become unaffordable due to commercial exploitation. In some cases, patents filed by corporations can prohibit the use or sale of resources by the very communities that discovered their properties. This not only creates economic hardship but also threatens the preservation of traditional knowledge and biodiversity conservation efforts.

International frameworks addressing IPR and biopiracy 🔗

The Convention on Biological Diversity 🔗

The Convention on Biological Diversity (CBD), established in 1992, represents a comprehensive approach to addressing these challenges. The CBD has three main objectives: conservation of biological diversity, sustainable use of its components, and fair and equitable sharing of benefits arising from genetic resources. It recognizes that countries have sovereign rights over their biological resources and emphasizes that exploitation should involve local communities with equitable benefit-sharing.

The Nagoya Protocol 🔗

Building on the CBD framework, the Nagoya Protocol was adopted in 2010 and entered into force in 2014. This supplementary agreement provides concrete mechanisms to ensure fair access and benefit-sharing of genetic resources. The protocol requires that countries give prior informed consent before biological material is collected or transferred, and it mandates that benefits from utilizing genetic resources be shared with source communities.

The Nagoya Protocol establishes legal certainty for both providers and users of genetic resources. It applies to genetic resources covered by the CBD and to traditional knowledge associated with these resources. Through material transfer agreements and mutually agreed terms, the protocol aims to prevent biopiracy while facilitating legitimate research and development.

WIPO’s role in protecting traditional knowledge 🔗

The World Intellectual Property Organization (WIPO) has established an Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore to address the intersection between IPR and traditional knowledge. This committee works toward international legal instruments that would prevent misappropriation of traditional knowledge, ensure consideration of traditional knowledge in patent examinations, and create positive rights giving communities control over their knowledge. In May 2024, WIPO adopted a landmark treaty on intellectual property, genetic resources and associated traditional knowledge, marking significant progress in addressing these concerns.

Balancing innovation and fairness 🔗

The challenge lies in creating a system that both encourages biotechnology innovation and protects the rights of communities and nations over their biological resources. IPR protection remains essential for attracting investment in biotechnology research, which requires substantial funding and carries high risks. However, this protection must not come at the expense of exploiting traditional knowledge or depleting biodiversity resources that communities need for their own use.

Countries like India have developed comprehensive legal frameworks to address these challenges. The Biological Diversity Act implements India’s obligations under the CBD while establishing mechanisms to regulate access to biological resources by foreign entities. National Biodiversity Authorities in such countries work to ensure that access requires proper authorization and that benefits are shared equitably with local communities.

Moving forward ethically 🔗

Achieving balance requires multiple stakeholders to work together. Researchers must recognize and respect traditional knowledge when conducting bioprospecting activities. Companies need to implement ethical practices that include obtaining prior informed consent, establishing fair benefit-sharing agreements, and investing in local conservation efforts. Policymakers must continue refining international frameworks to address emerging challenges, including digital biopiracy and new biotechnology applications.

The future of biotechnology depends on our ability to foster innovation while ensuring equity and sustainability. This means protecting intellectual property rights to encourage continued research and development, while simultaneously safeguarding biological resources and traditional knowledge from exploitation. When these goals align, biotechnology can advance in ways that benefit both innovators and the communities that have preserved biological diversity and traditional knowledge for generations.

What do you think? How can biotechnology companies better ensure they’re respecting traditional knowledge when developing new products? What role should governments play in protecting both innovation and biological resources in your country?

References

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC3815763/
2. https://ustr.gov/trade-agreements/wto-multilateral-affairs/-world-trade-organization/council-trade-related-aspects-in
3. https://en.wikipedia.org/wiki/Biopiracy
4. https://theconversation.com/biopiracy-when-indigenous-knowledge-is-patented-for-profit-55589
5. https://en.wikipedia.org/wiki/Convention_on_Biological_Diversity
6. https://en.wikipedia.org/wiki/Nagoya_Protocol
7. https://en.wikipedia.org/wiki/World_Intellectual_Property_Organization